[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367599-105":59,"doc-detail-367599-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-epigenetic-landscape-of-brain-metastasis-review","The epigenetic landscape of brain metastasis - Review","","Brain metastasis poses a major oncology challenge driven by intricate molecular and epigenetic processes that set metastatic lesions apart from primary tumors. While genomic analyses have identified mutation drivers with potential clinical value, they have not defined specific genetic mutations that account for site-specific brain metastasis. Effective brain colonization depends on transcriptional adaptation and specialized molecular traits, including widespread dysregulated gene programs enabling extravasation, seeding, and outgrowth, with evidence implicating epigenetic mechanisms.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-epigenetic-landscape-of-brain-metastasis-review/367599/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-epigenetic-landscape-of-brain-metastasis-review/367599.png","ImageObject",300,407,{"name":92,"@type":93},"Rizky","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is brain metastasis considered a distinct challenge in oncology?","Question",{"text":112,"@type":113},"Brain metastasis involves secondary tumors in the CNS and is shaped by complex molecular and epigenetic mechanisms that differ from primary tumors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What limits the usefulness of genomic mutation-driven strategies for brain metastasis?",{"text":117,"@type":113},"Identifying genomic mutation drivers has not pinpointed specific genetic mutations responsible for site-specific metastasis to the brain.",{"name":119,"@type":110,"acceptedAnswer":120},"How do epigenetic mechanisms contribute to brain metastatic success?",{"text":121,"@type":113},"Epigenetic regulation shapes pro-brain metastatic traits through dysregulated chromatin patterns, including chromatin remodeling, histone modifications, and DNA/RNA methylation, supporting seeding, initiation, and outgrowth.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367599,1790245598,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085564807,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Oncogene [www.nature.com/onc](www.nature.com/onc)  \nREVIEW ARTICLE OPEN   \nThe epigenetic landscape of brain metastasis  \nAoibhín M. Powell 1, Louise Watson 2, Lara Luzietti 1, Stefan Prekovic 3, Leonie S. Young 2,4,5 ✉ and Damir Varešlija1,4,5 ✉  \n© The Author(s) 2025  \n\n|  | Brain metastasis represents a signiﬁcant challenge in oncology, driven by complex molecular and epigenetic mechanisms that distinguish it from primary tumors. While recent research has focused on identifying genomic mutation drivers with potential clinical utility, these strategies have not pinpointed speciﬁc genetic mutations responsible for site-speciﬁc metastasis to the brain. It is now clear that successful brain colonization by metastatic cancer cells requires intricate interactions with the brain tumor ecosystem and the acquisition of specialized molecular traits that facilitate their adaptation to this highly selective environment. This is best exempliﬁed by widespread transcriptional adaptation during brain metastasis, resulting in aberrant gene programs that promote extravasation, seeding, and colonization of the brain. Increasing evidence suggests that epigenetic mechanisms play asigniﬁcant role in shaping these pro-brain metastasis traits. This review explores dysregulated chromatin patterns driven by chromatin remodeling, histone modiﬁcations, DNA/RNA methylation, and other epigenetic regulators that underpin brain metastatic seeding, initiation, and outgrowth. We provide novel insights into how these epigenetic modiﬁcations arise within both the brain metastatic tumor and the surrounding brain metastatic tumor ecosystem. Finally, we discuss how the inherent plasticity |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| and reversibility of the epigenomic landscape in brain metastases may offer new therapeutic opportunities. |  |  |\n|  | Oncogene (2025) 44:2227–2239; [https://doi.org/10.1038/s41388-025-03315-1](https://doi.org/10.1038/s41388-025-03315-1) |  |\n|  |  |  |\n\nINTRODUCTION  \nClinical overview, epidemiology, and molecular mechanisms of brain metastasis  \nThe majority of cancer-related deaths arise from metastasis rather than the primary tumor. Brain metastasis (BrM), involving the central nervous system (CNS), represents a critical stage of this process. BrM are secondary tumors that originate from primary cancers elsewhere in the body and spread to the brain. This is distinct from primary brain tumors, such as gliomas and glioblastomas, which originate from cells within the brain itself. Despite its severity, BrM mechanisms remain underexplored, limiting therapeutic options [1] . BrM primarily originates from lung (20–56%), breast (5–20%), and melanoma (7–16%) cancers [2–6], with a rising incidence in renal cell carcinoma (RCC) and gastrointestinal (GI) cancers [7] . Molecular subtype of the primary tumor inﬂuences BrM likelihood, as seen in ALK-rearranged and KRAS-mutated non-small cell lung cancer (NSCLC) [8], or human epidermal growth factor receptor (HER) 2-positive and triplenegative breast cancer (TNBC) subtypes, which manifest earlier metastasis compared to estrogen receptor-positive (ER+) tumors [9–12] .  \nBrM is usually associated with advanced stages of primary disease [2, 13, 14], with factors such as ethnicity, age, and location inﬂuencing risk [2, 15] . For example, African Americans show higher BrM incidence for lung, melanoma, and breast cancers, though lower rates for RCC [2, 15] . Younger patients (aged 20–39) are more likely to develop breast cancer BrM, while lung cancer peaks in middle age, and melanoma, RCC, and colorectal cancer BrM appear more commonly after age 50 [2, 15, 16] . Though  \noverall survival has improved, it remains low, with median survival for BrM patients ranging from 7 to 34 months depending on cancer type [17] . Symptoms include seizures, headaches, and cognitive impairment, all of which impact quality of li","cbCaityEJZt5de7m","https://ap.wps.com/l/cbCaityEJZt5de7m","pdf",1641307,13,"English","# INTRODUCTION\n## Clinical overview, epidemiology, and molecular mechanisms of brain metastasis","[{\"question\":\"Why is brain metastasis considered a distinct challenge in oncology?\",\"answer\":\"Brain metastasis involves secondary tumors in the CNS and is shaped by complex molecular and epigenetic mechanisms that differ from primary tumors.\"},{\"question\":\"What limits the usefulness of genomic mutation-driven strategies for brain metastasis?\",\"answer\":\"Identifying genomic mutation drivers has not pinpointed specific genetic mutations responsible for site-specific metastasis to the brain.\"},{\"question\":\"How do epigenetic mechanisms contribute to brain metastatic success?\",\"answer\":\"Epigenetic regulation shapes pro-brain metastatic traits through dysregulated chromatin patterns, including chromatin remodeling, histone modifications, and DNA/RNA methylation, supporting seeding, initiation, and outgrowth.\"}]","The epigenetic landscape of brain metastasis - Review | PDF",1790171583,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b96ac07389f805d2be13eec8a65dc4ca.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/592af9476bf3a45c752c44dd2de75927.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/034e586c4260c662ab744c557662523d.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/794caef6dc16654dc70f9ddeeb6ac805.webp",980,1301]